Pykus Therapeutics announced it has completed enrollment in its pilot study, PYK-2101-RD00, evaluating PYK-2101, a focal hydrogel retinal sealant, in patients undergoing surgery for detached retina.

A team of Chinese researchers reported that fasting C-peptide (FCP) has a complicated relationship with the development of diabetic retinopathy (DR). Below a specific threshold, FCP exerts a ...

Novelty Nobility, a Korean antibody drug discovery company, recently announced it has been selected to join JLABS Korea. 1 JLABS, part of Johnson & Johnson’s global incubator network, supports ...

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset. Taiwanese investigators found in their cohort ...

A study on the effects of methylphenidate in children with ADHD found that treated children had lower corneal endothelial cell counts compared to untreated children and a control group. A study of the ...

The ZAP-X system is described by researchers as a "dedicated, self-contained, and self-shielded surgical robot" designed for performing stereotactic surgery (SRS) on the brain, head, and neck. This ...

Opus Genetics issued a press release today announcing the 1-month open-label phase 1/2 results from the first pediatric patients treated with its investigational gene therapy candidate, OPGx-LCA5, for ...

Ocular signs may be early indicators of multiple myeloma or relapse, and early recognition and collaboration between hematologists and ophthalmologists can improve outcomes. The results of a recent ...

Tertiary syphilis, which can develop years to decades after the initial infection, is characterized by chronic inflammatory damage affecting multiple organ systems. Ocular syphilis, a potential ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic retinopathy compared to telemedicine evaluations. Researchers from the ...

In the month of March, not only did trials progress, but approvals for new and expanded uses of treatments were issued. With companies around the globe working to development new candidates for ...